Raymond James & Associates INVIVO THERAPEUTICS HLDGS CO Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
N/A
-74,000 Closed
0 $0
Q1 2018

May 14, 2018
SELL
N/A
-5,400 Reduced 6.8%
74,000 $40,000
Q4 2017

Feb 14, 2018
SELL
N/A
-7,433 Reduced 8.56%
79,400 $61,000
Q3 2017

Nov 13, 2017
BUY
N/A
35,400 Added 68.83%
86,833 $126,000
Q2 2017

Aug 14, 2017
BUY
N/A
51,433
51,433 $139,000
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email